Stay updated on Immuno-Radiotherapy for Recurrent Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Immuno-Radiotherapy for Recurrent Gastric Cancer Clinical Trial page.
Latest updates to the Immuno-Radiotherapy for Recurrent Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedThe website has been updated from version 2.11.0 to 2.11.2, indicating new features or improvements.SummaryDifference0.1%
- Check10 days agoChange DetectedThe study results for a clinical trial on localized short-term radiotherapy combined with nivolumab for unresectable recurrent gastric cancer have been posted, detailing treatment protocols, patient eligibility criteria, and outcomes such as disease control rates and overall survival.SummaryDifference57%
- Check18 days agoChange DetectedClinicalTrials.gov is addressing delays in displaying study record information, and the site has been updated to version 2.10.5, replacing the previous version 2.10.3.SummaryDifference0.9%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe website has been updated from version 2.10.2 to 2.10.3.SummaryDifference0.1%
- Check53 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check75 days agoChange DetectedThe study has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.4%
Stay in the know with updates to Immuno-Radiotherapy for Recurrent Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immuno-Radiotherapy for Recurrent Gastric Cancer Clinical Trial page.